Latest respiratory tract infection News | Page 2

Tezspire approved in EU for treatment of severe asthma
Beyfortus recommended for approval in EU by CHMP for prevention of RSV lower respiratory tract disease in infants
Tezspire recommended for approval in EU by CHMP for treatment of severe asthma
Ultomiris recommended for approval in EU by CHMP for treatment of adults with generalised myasthenia gravis
Study confirms ED cases spike after Australian bushfires
Support Us to Support You to Stay Well this Winter
Combination nasal spray Ryaltris now approved for Australian children aged six years and older with hay fever or other year-round
Study to test anti-viral effects of Lactoferrin
Nirsevimab significantly protected infants against RSV disease in Phase III MELODY trial
Bacteria in nose may increase risk of Alzheimer’s disease – study
Nirsevimab EMA regulatory submission accepted under accelerated assessment for RSV protection in all infants
Saphnelo approved in EU for treatment of moderate to severe systemic lupus erythematosus
Saphnelo recommended for approval in EU by CHMP for treatment of patients with systemic lupus erythematosus
Tezspire approved in US for severe asthma
Zinc shown to prevent symptoms and shorten duration of common cold and flu-like illnesses
Saphnelo approved in Japan for systemic lupus erythematosus
Identifying risk of unplanned emergency department transfer in aged care